Skip to main content
KANABO GROUP PLC logo

KANABO GROUP PLC — Investor Relations & Filings

Ticker · KNB ISIN · GB00BYQCS703 LEI · 213800XPJFSNWJIYKN52 IL Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2022-01-18 Regulatory Filings
Country GB United Kingdom
Listing IL KNB

About KANABO GROUP PLC

https://www.kanabogroup.com/

Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.

Recent filings

Filing Released Lang Actions
Materia Announces Trading Update for 4Q22
Regulatory Filings Classification · 98% confidence The document starts with an RNS Number and is dated 18 January 2022. The title explicitly states it is a 'Trading Update for 4Q22' concerning Materia, a company Kanabo Group Plc is acquiring. The content discusses Materia's Q4 2021 performance, sales growth, and operational milestones. This is an announcement providing key financial highlights for a specific period (Q4 2021/4Q22), which aligns best with the Earnings Release (ER) definition, which covers initial announcements of periodical financial results (key highlights only). Although it references another company's update, the primary purpose of this RNS filing by Kanabo is to report on the performance relevant to its strategic interests, functioning as an earnings/trading update announcement. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR). Since it is a formal announcement distributed via RNS, and it contains financial performance highlights, ER is the most appropriate classification over the general fallback RNS.
2022-01-18 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1933 characters) and contains the header 'RNS Number : 6970X'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or DLST), the most appropriate classification is the general regulatory filing fallback category.
2022-01-06 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1916 characters) and contains the header 'RNS Number : 6956X'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement that does not fit into specific financial reporting categories like 10-K, ER, or IR. Therefore, it should be classified as a general Regulatory Filing (RNS).
2022-01-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the header "RNS Number : 2116X" and explicitly states it is provided by RNS, the news service of the London Stock Exchange. The content announces the 'Total Voting Rights' as of 31 December 2021, providing the total number of ordinary shares (369,966,277) to be used as the denominator for shareholder notification calculations under the FCA's Disclosure Guidance and Transparency Rules. This type of mandatory regulatory disclosure, which is short and serves as a general announcement via the RNS system, fits best under the 'Regulatory Filings' category, as it is not a specific financial report (like 10-K or IR) or a specific corporate action announcement (like DIV or SHA). Given the context of RNS distribution and the nature of the announcement, RNS is the most appropriate code.
2021-12-31 English
Grant of Options
Remuneration Information Classification · 99% confidence The document is identified by the 'RNS Number' header and contains information typical of a regulatory news service announcement from the London Stock Exchange. The content explicitly details the 'Grant of Options' to employees, including a Person Discharging Managerial Responsibilities (PDMR), and includes a 'Notification of Dealing Form' as required by Market Abuse Regulation. This type of announcement, which reports insider transactions (even if options grants are involved, which often trigger similar disclosure requirements as dealings), is a specific type of regulatory disclosure. While it relates to insider transactions (DIRS), the primary structure and context (RNS Number, LSE distribution, general regulatory update) strongly suggest a general regulatory filing category. However, since it specifically details transactions/grants involving directors/managers, the 'Director's Dealing' (DIRS) code is highly relevant. Given the explicit inclusion of the PDMR and the detailed transaction table mirroring insider disclosure rules, DIRS is the most specific fit over the general RNS fallback. The document is not a full report, but a specific announcement.
2021-12-31 English
Achievement of Milestones
Share Issue/Capital Change Classification · 99% confidence The document begins with 'RNS Number' and is distributed via 'RNS, the news service of the London Stock Exchange,' which strongly suggests a regulatory announcement. The content discusses the 'Achievement of Milestones' leading to the 'Issue of Deferred Consideration Shares' and the subsequent 'Issue of Equity' (38,461,492 new ordinary shares). This is a corporate action announcement related to a prior agreement (SPA) and milestone achievement, which is a type of material event disclosure. Since it is a general regulatory announcement disseminated through the official news service (RNS) and does not fit neatly into specific categories like Director's Dealing (DIRS), Capital Change (SHA), or Dividend Notice (DIV), the most appropriate classification is the general regulatory filing category.
2021-12-30 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.